SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : INHL - Inhale Therapeutics - Pulmonary Insulin!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Ross who wrote (77)2/4/1998 10:30:00 PM
From: Marvin Frank  Read Replies (1) of 225
 
Dear Dan, As a physician I feel the potential for growth is excellent as pointed out in recent Business Week article but stock only rose
1 1/2 pts and then dropped. It appears that INHL is overpriced. The idea of inhalation to absorb systemic drugs or insulin is medically feasible and pioneering. There is a competitor you might like to check out: Aradigm (ARDM) at a price of $10approx.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News